Dosage Chart

KPV Dosage Chart

KPV dosage chart — reconstitution of a 5 mg vial, tiered subcutaneous and oral protocols with exact unit math, and safety guidance.

Last updated · 2026-08-04
Where to buy KPV
KPV11 vetted vendors

Save 15% with code VIALBASE

See all 11 sources →

VialBase may earn a commission on partner links — never at extra cost to you. Disclosure.

Reconstitution

5 mg KPV vial in 2 mL bacteriostatic water

Reconstituted at 5 mg / 2 mL, the vial holds 2,500 mcg/mL. On a U-100 syringe, 10 units = 0.1 mL = 250 mcg; 8 units = 200 mcg; 20 units = 500 mcg.

The KPV dosage chart covers reconstitution of a standard 5 mg vial and the tiered subcutaneous and oral protocols below, with the exact unit math for each dose. KPV is an anti-inflammatory tripeptide used for inflammatory skin and gut concerns.

Dosage protocols

Low (titration / gut)

8 units · 0.08 mL · 0.2 mg KPV
Once daily
Cycle: 4–8 weeks

200 mcg is the low end of the common range and a sensible starting point for gut-focused use, where KPV's oral bioavailability also makes capsules an option.

Your vial, your numbers

Different vial size or water volume? Recalculate your exact draw.

KPV blend

Syringe Size

Draw to mark

20u(0.200 mL)

Concentration

2500 mcg / mL

For research purposes only. Verify all calculations independently before use.

020406080100
20u
100u syringe

From vial to injection

  1. Sanitize Wipe the KPV vial stopper and the bacteriostatic-water stopper with fresh alcohol swabs and let them dry.
  2. Draw the diluent Draw 2 mL of bacteriostatic water into a reconstitution syringe.
  3. Add water slowly Angle the needle so the water runs down the inside wall of the vial rather than onto the powder.
  4. Swirl, don't shake Gently swirl until fully dissolved. Never shake.
  5. Draw your dose With a U-100 insulin syringe, draw to your tier's unit mark (8 units = 200 mcg, 20 units = 500 mcg).
  6. Inject or take orally Inject subcutaneously (rotate sites) or use the oral/topical route. Store reconstituted vial at 2–8 °C, use within 28 days.

Feeling something? Check here

Normal — expected
  • Mild, transient injection-site redness or itch that fades within an hour
  • No systemic effect — KPV is generally well tolerated at these doses
Back off & reassess
  • Persistent GI upset or headache — space dosing and confirm sterile reconstitution
  • Injection-site lumps or swelling lasting more than a day — rotate sites, check technique
Stop & seek care
  • Facial or throat swelling, difficulty breathing, hives — stop and seek emergency care (allergic reaction)
  • Spreading redness, heat, pus, or fever at an injection site — signs of infection

General subcutaneous-peptide safety guidance; KPV has a favorable tolerability profile in preclinical anti-inflammatory studies.

This self-check is educational, not a diagnosis. When in doubt, stop dosing and consult a qualified healthcare provider.

Frequently Asked Questions

How do you dose KPV?
Reconstitute a 5 mg vial with 2 mL bacteriostatic water (2,500 mcg/mL). Common dosing is 200–500 mcg once or twice daily — 8 units on a U-100 syringe is 200 mcg, 20 units is 500 mcg. KPV is used subcutaneously, orally, or topically; cycle roughly 4–8 weeks.
Can KPV be taken orally?
Yes. KPV's oral bioavailability makes capsules a practical option, especially for gut applications. Oral dosing typically mirrors the 200–500 mcg, 1–2× daily range.
Is KPV FDA-approved?
No. KPV is research-use-only in the US and not on the 503A bulks list or in any FDA interim compounding category. Community dosing guides are a starting point, not medical advice.

Sources

⚠️ KPV side effects — common, serious & how to reduce them →

Full KPV research page →